Meanwhile, mutations of the SETD2 gene are common (occurs up to 12%) in ccRCC patients10, thus indicating that SETD2 deficiency may indeed play a crucial role in the development of ccRCC but not PKD. Here, SETD2 is linked to nonpapillary renal cell carcinoma.